Cabanib 60 mg (Cabozantinib)

Cabanib 60 mg (Cabozantinib), general Cometriq is a traditional drug used to treat metastatic medullary thyroid cancer (MTC). This drug blocks the action of a particular enzyme from working which helps to decelerate or stop the spread of cancer cells.
Cabanib ( General Cabozantinib) is manufactured by Drug InternationalLtd. in Bangladesh.
Have to take orally formerly a day on an empty stomach ( Don’t eat for at least 2 hours ahead and at least 1 hour after taking the cure)

Side Effects
The most common adverse responses are
Dizziness, diarrhea, nauseapukingmouth blisters, constipation, stomach painfrazzleweaknessweight lossdropped appetitetaste changes, hoarseness, and lightening of hair color.

The below information comes from the Internet. Please consult with the croaker for medical advice.

error: Content is protected !!